Kazumasa Otsubo
Direktor/Vorstandsmitglied bei KAINOS LABORATORIES, INC.
Aktive Positionen von Kazumasa Otsubo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KAINOS LABORATORIES, INC. | Direktor/Vorstandsmitglied | 01.06.2014 | - |
Asahi Kasei Pharma Corp.
 Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Corporate Officer/Principal | 01.04.2013 | - |
Karriereverlauf von Kazumasa Otsubo
Statistik
International
| Japan | 3 |
Operativ
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KAINOS LABORATORIES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Finance |
- Börse
- Insiders
- Kazumasa Otsubo
- Erfahrung
